High Response Rate Seen With CD19 CAR T-Cell Therapy in CLL – www.oncnursingnews.com/
|
High Response Rate Seen With CD19 CAR T-Cell Therapy in CLL
www.oncnursingnews.com/ Treatment with CD19 chimeric antigen receptor (CAR)-modified T–cell therapy induced a high response rate in patients with high-risk, ibrutinib-refractory chronic lymphocytic leukemia (CLL), according to results recently published in the Journal of … |
